Influvac Sospensione iniettabile
Land: Schweiz
Sprog: italiensk
Kilde: Swissmedic (Swiss Agency for Therapeutic Products)
Send anmodning.
Aktiv bestanddel:
haemagglutininum influenzae di tipo A (H1N1) (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus A/Brisbane/02/2018, IVR-190), haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Kansas/14/2017 (H3N2)-come: reassortant virus A/Kansas/14/2017, NYMC X-327), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-come: reassortant virus B/Veneto/15/2016 NYMC BX-69A)
Tilgængelig fra:
Mylan Pharma GmbH
ATC-kode:
J07BB02
INN (International Name):
haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus A/Brisbane/02/2018, IVR-190), haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Kansas/14/2017 (H3N2)-like: reassortant virus A/Kansas/14/2017, NYMC X-327), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A)
Lægemiddelform:
Sospensione iniettabile
Sammensætning:
haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus A/Brisbane/02/2018, IVR-190) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Kansas/14/2017 (H3N2)-like: reassortant virus A/Kansas/14/2017, NYMC X-327) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: natrii citras dihydricus max. 1 mg, cetrimidum max. 15 µg, formaldehydum max. 10 µg, gentamicini sulfas max. 1 ng, tylosini tartras nihil, hydrocortisonum nihil, polysorbatum 80 nihil, ovalbuminum max. 0.1 µg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.
Klasse:
B
Terapeutisk gruppe:
Vaccini
Terapeutisk område:
Immunizzazione attiva contro l'Influenza, che abbiano compiuto il 6. Mese di vita
Autorisation dato:
1988-06-24
